SI0906294T1 - Benzoxazinone dopamine d4 receptor antagonists - Google Patents

Benzoxazinone dopamine d4 receptor antagonists

Info

Publication number
SI0906294T1
SI0906294T1 SI9730482T SI9730482T SI0906294T1 SI 0906294 T1 SI0906294 T1 SI 0906294T1 SI 9730482 T SI9730482 T SI 9730482T SI 9730482 T SI9730482 T SI 9730482T SI 0906294 T1 SI0906294 T1 SI 0906294T1
Authority
SI
Slovenia
Prior art keywords
benzoxazinone
dopamine
receptor antagonists
antagonists
receptor
Prior art date
Application number
SI9730482T
Other languages
English (en)
Slovenian (sl)
Inventor
Thomas Belliotti
Lawrence David Wise
David Juergen Wustrow
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of SI0906294T1 publication Critical patent/SI0906294T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI9730482T 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists SI0906294T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1838396P 1996-05-29 1996-05-29
US4020897P 1997-03-06 1997-03-06
PCT/US1997/008524 WO1997045419A1 (en) 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists
EP97925651A EP0906294B1 (en) 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists

Publications (1)

Publication Number Publication Date
SI0906294T1 true SI0906294T1 (en) 2003-04-30

Family

ID=26691052

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730482T SI0906294T1 (en) 1996-05-29 1997-05-20 Benzoxazinone dopamine d4 receptor antagonists

Country Status (37)

Country Link
EP (1) EP0906294B1 (xx)
JP (1) JP2000511534A (xx)
KR (1) KR20000016151A (xx)
CN (1) CN1074764C (xx)
AR (1) AR008372A1 (xx)
AT (1) ATE231846T1 (xx)
AU (1) AU731104B2 (xx)
BG (1) BG64049B1 (xx)
BR (1) BR9709630A (xx)
CA (1) CA2253406A1 (xx)
CO (1) CO4940505A1 (xx)
CZ (1) CZ384698A3 (xx)
DE (1) DE69718786T2 (xx)
DK (1) DK0906294T3 (xx)
EA (1) EA001486B1 (xx)
EE (1) EE03686B1 (xx)
ES (1) ES2191180T3 (xx)
GE (1) GEP20012389B (xx)
HK (1) HK1019737A1 (xx)
HN (1) HN1997000075A (xx)
HR (1) HRP970301B1 (xx)
HU (1) HUP9903758A3 (xx)
ID (1) ID17266A (xx)
IL (1) IL126895A (xx)
NO (1) NO312296B1 (xx)
NZ (1) NZ332737A (xx)
PA (1) PA8431101A1 (xx)
PE (1) PE69398A1 (xx)
PL (1) PL330195A1 (xx)
PT (1) PT906294E (xx)
RO (1) RO120845B1 (xx)
SI (1) SI0906294T1 (xx)
SK (1) SK282703B6 (xx)
SV (1) SV1997000047A (xx)
TW (1) TW542833B (xx)
UY (1) UY24569A1 (xx)
WO (1) WO1997045419A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
WO2000000489A2 (en) * 1998-06-30 2000-01-06 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
EP1089990A1 (en) * 1998-06-30 2001-04-11 Neurogen Corporation 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands
DE19844291A1 (de) 1998-09-18 2000-03-23 Schering Ag Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
BR0114881A (pt) 2000-10-26 2003-09-30 Smithkline Beecham Plc Derivados de benzoxazinona, sua preparação e uso
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
KR200482995Y1 (ko) 2015-08-19 2017-03-23 이현진 물 공급부를 구비하는 얼음 트레이
CN115232154A (zh) * 2021-04-23 2022-10-25 上海翰森生物医药科技有限公司 杂环类衍生物抑制剂、其制备方法和应用
WO2023207283A1 (en) * 2022-04-28 2023-11-02 Ningbo Newbay Technology Development Co., Ltd Compounds as parp1 inhibitiors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
NZ254784A (en) * 1992-08-06 1996-11-26 Smithkline Beecham Plc Substituted 5-phenyl pyrrole derivatives and medicaments

Also Published As

Publication number Publication date
ATE231846T1 (de) 2003-02-15
CO4940505A1 (es) 2000-07-24
BR9709630A (pt) 1999-08-10
TW542833B (en) 2003-07-21
PT906294E (pt) 2003-06-30
EP0906294A1 (en) 1999-04-07
DK0906294T3 (da) 2003-05-05
NO985531D0 (no) 1998-11-27
HRP970301B1 (en) 2002-08-31
CN1074764C (zh) 2001-11-14
PL330195A1 (en) 1999-04-26
AU3072797A (en) 1998-01-05
EA199800987A1 (ru) 1999-06-24
EA001486B1 (ru) 2001-04-23
PE69398A1 (es) 1998-12-02
KR20000016151A (ko) 2000-03-25
HUP9903758A2 (hu) 2000-06-28
HUP9903758A3 (en) 2000-07-28
EP0906294B1 (en) 2003-01-29
NZ332737A (en) 2000-06-23
BG102959A (en) 1999-08-31
WO1997045419A1 (en) 1997-12-04
CZ384698A3 (cs) 1999-03-17
HK1019737A1 (en) 2000-02-25
JP2000511534A (ja) 2000-09-05
GEP20012389B (en) 2001-03-25
DE69718786D1 (de) 2003-03-06
HN1997000075A (es) 1997-07-30
RO120845B1 (ro) 2006-08-30
PA8431101A1 (es) 2001-12-14
BG64049B1 (bg) 2003-11-28
UY24569A1 (es) 2001-08-27
AU731104B2 (en) 2001-03-22
EE9800417A (et) 1999-06-15
ID17266A (id) 1997-12-18
CN1219930A (zh) 1999-06-16
NO985531L (no) 1998-11-27
HRP970301A2 (en) 1998-04-30
SK162798A3 (en) 1999-06-11
NO312296B1 (no) 2002-04-22
AR008372A1 (es) 2000-01-19
ES2191180T3 (es) 2003-09-01
SK282703B6 (sk) 2002-11-06
IL126895A (en) 2001-06-14
CA2253406A1 (en) 1997-12-04
EE03686B1 (et) 2002-04-15
SV1997000047A (es) 1998-08-13
DE69718786T2 (de) 2003-10-23
IL126895A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
HUP9903445A3 (en) 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
ZA975671B (en) IL-8 receptor antagonists.
HU9603525D0 (en) Vironectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
HK1019737A1 (en) Benzoxazinone dopamine d4 receptor antagonists
GB9625843D0 (en) Phenyl spiroethercycloalkyl tachykinn receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0998285A4 (en) ANTAGONISTS OF THE ALPHA 1a ADRENERIC RECEPTOR
ZA977301B (en) IL-8 receptor antagonists.
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
GR3036032T3 (en) Oxa- and thia-diazole muscarinic receptor antagonists
EP1023068A4 (en) ALPHA 1a ADRENORE RECEPTOR ANTAGONISTS
AU6230698A (en) Dopamine d4 receptor antagonist
EP1014973A4 (en) ANTAGONISTS OF ALPHA 1a ADRENORECEPTORS
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU1735100A (en) Isoxazoline fibrinogen receptor antagonists
ZA974684B (en) Benzoxazinone dopamine D4 receptor antagonists.
ZA977445B (en) Troponyl piperazines as dopamine D4 receptor ligands.
EP0957908A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9708766D0 (en) Fibrinogen receptor antagonist
GB9603371D0 (en) Fibrinogen receptor antagonists
GB9606489D0 (en) Fibrinogen receptor antagonists
GB9613688D0 (en) Fibrinogen receptor antagonists
GB9603423D0 (en) Alpha la adrenergic receptor antagonists